Lobe Sciences partners with iNGENū for new clinical trials in Australia

Mugglehead
By Rowan DunneAug 12, 2022, 9:14 pm205 pts
Three or more trials evaluating the efficacy of two psilocin analogues will soon be falling into the hands of one contract research organization (CRO) in Australia. On Wednesday, Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) revealed that it had entered into an exclusive agreement with iNGENū Pty Ltd. to…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Minnesota issues first adult-use marijuana license to a cultivator 68

PinkPepper Genome Mapping Transforms CBD Hemp Cultivation and Research 68

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.